In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines
- PMID: 9439685
- PMCID: PMC5921319
- DOI: 10.1111/j.1349-7006.1997.tb00334.x
In vitro efficacy of anti-glial fibrillary acidic protein monoclonal antibodies against human malignant glioma cell lines
Abstract
Our studies have confirmed the presence of large concentrations of various intermediate filament proteins (IFPs) in glioma tissue compared to normal brain. This avenue of research was extended to assess the anti-proliferative activity of anti-intermediate filament protein monoclonal antibodies (anti-IFP mAbs) against human glioma cells. In this study, anti-proliferative activity of glial fibrillary acidic protein monoclonal antibodies (anti-GFAP mAbs) has been tested in vitro, using glioma cell lines prepared and established from freshly resected brain tumors. One anaplastic astrocytoma (AA), two glioblastoma multiforme (GB1 and GB2) cell lines and three anti-GFAP mAbs (B12C4, B12B4 and B6C6, all IgG1, kappa) were used. Immunofluorescence study indicated the ability of anti-GFAP mAbs to recognize the cell surface of glioma cells and the inhibition study showed that mAb B12B4 inhibited the proliferation of GB1 (96%), GB2 (85%) and AA (93%) at a concentration of 3.2 x 10(-10) M. mAb B12C4 inhibited the proliferation of GB1 (95%), GB2 (86%) and AA (94%) at a concentration of 3.26 x 10(-10) M and mAb B6C6 inhibited the proliferation of GB1 (75%), GB2 (75%) and AA (91%) at a concentration of 2.074 x 10(-10) M. Thymidine release assay demonstrated the cytolytic activities of anti-GFAP mAbs towards these glioma cell lines, and this observation was confirmed by dye exclusion, which indicated the lysis of glioma cells after anti-GFAP mAbs treatment. Anti-GFAP mAbs had little effect (< or = 20%) on normal human lymphocyte, liver and intestine cell lines. These results look promising for radioimaging and immunotherapy of human gliomas.
Similar articles
-
Human glioma associated intermediate filament proteins: over-expression, co-localization and cross-reactivity.Anticancer Res. 1998 Mar-Apr;18(2B):1333-40. Anticancer Res. 1998. PMID: 9615812
-
In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies.Br J Cancer. 1998 Dec;78(12):1578-85. doi: 10.1038/bjc.1998.726. Br J Cancer. 1998. PMID: 9862567 Free PMC article.
-
Anti-urokinase-type plasminogen activator monoclonal antibodies inhibit the proliferation of human breast cancer cell lines in vitro.Tumour Biol. 1998;19(4):229-37. doi: 10.1159/000030012. Tumour Biol. 1998. PMID: 9679732
-
Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas.Neuro Oncol. 2011 Jan;13(1):42-50. doi: 10.1093/neuonc/noq145. Epub 2010 Nov 12. Neuro Oncol. 2011. PMID: 21075782 Free PMC article.
-
Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.Acta Neuropathol. 1989;78(3):270-82. doi: 10.1007/BF00687757. Acta Neuropathol. 1989. PMID: 2475009
Cited by
-
Cancer Stem Cell Hierarchy in Glioblastoma Multiforme.Front Surg. 2016 Apr 15;3:21. doi: 10.3389/fsurg.2016.00021. eCollection 2016. Front Surg. 2016. PMID: 27148537 Free PMC article. Review.
References
-
- ) Silverberg , E. and Lubera , J. A.Cancer statistics . Cancer J. Clin. , 38 , 5 – 12 ( 1988. ). - PubMed
-
- ) Walker , M. D. , Greens , S. B. , Byar , D. P. , Alexander , E. , Batzdorf , U. , Brooks , W. H. , Hunt , W. E. , Mac‐Carty , C. S. , Mahaley , M. S. , Mealey , J. , Owens , G. , Ransohoff , J. , Robertson , J. T. , Shapiro , W. R. , Smith , K. R. , Wilson , C. B. and Strike , T. A.Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery , N. Engl J. Med. , 303 , 1323 – 1329 ( 1980. ). - PubMed
-
- ) Nazzaro , J. M. and Neuwelt , E. A.The role of surgery in the management of supratentorial intermediate and high grade astrocytomas in adults . Neurosurg. , 33 , 331 – 344 ( 1990. ). - PubMed
-
- ) Fuchs , E. and Weber , K.Intermediate filaments: structure, dynamics, function and disease . Annu, Rev. Biochem , 63 , 345 – 382 ( 1994. ). - PubMed
-
- ) Kymkowsky , M. W.Intermediate filaments: new proteins, some answers, more questions . Curr. Opin. Cell Biol , 7 , 46 – 54 ( 1995. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous